GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Albert David Ltd (BOM:524075) » Definitions » EBITDA Margin %

Albert David (BOM:524075) EBITDA Margin % : 22.47% (As of Mar. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Albert David EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Albert David's EBITDA for the three months ended in Mar. 2024 was ₹200 Mil. Albert David's Revenue for the three months ended in Mar. 2024 was ₹891 Mil. Therefore, Albert David's EBITDA margin for the quarter that ended in Mar. 2024 was 22.47%.


Albert David EBITDA Margin % Historical Data

The historical data trend for Albert David's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Albert David EBITDA Margin % Chart

Albert David Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.70 14.71 18.08 17.49 28.81

Albert David Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.79 33.85 30.12 28.59 22.47

Competitive Comparison of Albert David's EBITDA Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Albert David's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Albert David's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Albert David's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Albert David's EBITDA Margin % falls into.



Albert David EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Albert David's EBITDA Margin % for the fiscal year that ended in Mar. 2024 is calculated as

EBITDA Margin %=EBITDA (A: Mar. 2024 )/Revenue (A: Mar. 2024 )
=1044.317/3624.617
=28.81 %

Albert David's EBITDA Margin % for the quarter that ended in Mar. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=200.122/890.576
=22.47 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Albert David  (BOM:524075) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Albert David EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Albert David's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Albert David (BOM:524075) Business Description

Traded in Other Exchanges
Address
8, Netaji Subhas Road, D-Block, 3rd Floor, Gillander House, Kolkata, WB, IND, 700001
Albert David Ltd is engaged in the manufacturing and trading of pharmaceutical products. The company offers products such as pharmaceutical formulations, infusion solutions, herbal dosage forms, and bulk drugs. Its formulation product covers parenteral, oral, and enteral, topical agents, and vision care solutions. The company exports its product to regions like Latin America, South East Asia, and a few African countries.

Albert David (BOM:524075) Headlines

No Headlines